Siham Bibi

Cachan, 94235, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Th1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability.

Th1-Polarized, Dengue Virus-Activated Human Mast Cells Induce Endothelial Transcriptional Activation and Permeability.

Journal: Viruses
Published: October 06, 2020

In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis.

In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis.

Journal: Blood advances
Published: September 21, 2018

Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.

Tyrosine Kinase Inhibition in Mastocytosis: KIT and Beyond KIT.

Journal: Immunology and allergy clinics of North America
Published: July 16, 2018

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis.

Preclinical human models and emerging therapeutics for advanced systemic mastocytosis.

Journal: Haematologica
Published: May 04, 2018

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

Journal: Haematologica
Published: September 01, 2017

A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.

A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.

Journal: Oncotarget
Published: August 08, 2016

Molecular defects in mastocytosis: KIT and beyond KIT.

Molecular defects in mastocytosis: KIT and beyond KIT.

Journal: Immunology and allergy clinics of North America
Published: April 22, 2014

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.

A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.

Journal: Blood
Published: March 29, 2014

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.

Journal: Haematologica
Published: March 07, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026